Article Details

Jnana Therapeutics Launches With $50 Million Series A Financing to Target the Cell's Metabolic ...

Retrieved on: 2017-12-14 04:37:30

Tags for this article:

Click the tags to see associated articles and topics

Jnana Therapeutics Launches With $50 Million Series A Financing to Target the Cell's Metabolic .... View article details on hiswai:

Excerpt

<div>Our proprietary chemistry and biology platform allows us to systematically advance medicines based on the biology of these ancient information gathering systems,” said Amir Nashat, Ph.D., Managing Partner with <b>Polaris Partners</b> and Chief Executive at Jnana. “We are targeting a broad range of medical ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up